🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
QUR
$QURE
🔒 US EquitiesuniQure NV
AVG HISTORICAL GAP
-3.28%
MAX GAP RECORD
-41.20%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $QURE
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$QURE
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 09, 2026 Earnings Release 2026-11-09 (BEFORE OPEN (07:00)) | 🔮 UPCOMING 🔒 |
| Jul 29, 2026 Earnings Release 2026-07-29 (BEFORE OPEN) |
+3.66%
|
| May 05, 2026 Earnings Release 2026-05-05 (BEFORE OPEN) |
-2.76%
|
| Mar 02, 2026 Earnings Release 2026-03-02 (BEFORE OPEN) |
-41.20%
|
| Nov 10, 2025 Earnings Release 2025-11-10 (BEFORE OPEN) |
-4.64%
|
| Jul 29, 2025 Earnings Release 2025-07-29 (BEFORE OPEN) |
-1.60%
|
| May 09, 2025 Earnings Release 2025-05-09 (BEFORE OPEN) |
-0.82%
|
| Feb 27, 2025 Earnings Release 2025-02-27 (BEFORE OPEN) |
-3.94%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
5.0%
Bullish Gaps (4)
Bearish Gaps (8)
Neutral / Flat (3)
📖 Intelligence Summary
uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗